Janux Therapeutics, Inc.

JANXNASDAQHealthcareBiotechnology

$16.51- (-)1Y −35.28%

As of Oct 16, 2026 close

Market cap: $1.09B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $12.12$35.34
Volume (live): -
Avg. volume (3M): 905.34K

Janux Therapeutics, Inc. (JANX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Janux Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 12 professional research analysts

Consensus Rating

Buy

Based on 12 unique analysts

(13 total ratings in last 90 days)

High Confidence10.0:1 Buy/Sell

Average Price Target

$34.22

+107.27% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest JANX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 1, 2026	Swayampakula Ramakanth	HC Wainwright	Reiterates	Buy	$45.00
Sep 30, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 24, 2026	Kalpit Patel	Wolfe Research	Upgrades	Buy	$23.00
Aug 22, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Hold	-
Aug 13, 2026	Matt Phipps	William Blair	Maintains	Buy	-
Aug 11, 2026	Stephen Willey	Stifel Nicolaus	Maintains	Buy	$35.00
Aug 7, 2026	Oliver McCammon	LifeSci Capital	Maintains	Buy	$60.00
Aug 7, 2026	Boris Peaker	JonesTrading	Maintains	Buy	$28.00
Aug 7, 2026	Kelsey Goodwin	Piper Sandler	Maintains	Buy	$26.00
Aug 7, 2026	Supawat Thongthip	Truist	Maintains	Buy	-
Aug 7, 2026	Etzer Darout	Barclays	Maintains	Sell	$14.00
Aug 7, 2026	Alec Stranahan	BofA Securities	Reiterates	Buy	$21.00 → $22.00 +1.00 (+4.8%)
Aug 6, 2026	Bradley Canino	Guggenheim	Initiates Coverage	Buy	$58.00 → $55.00 −3.00 (−5.2%)

Swayampakula Ramakanth

HC Wainwright

BuyReiterates

$45.00

Oct 1

Zacks Equity Research

HoldInitiates Coverage

Sep 30

Kalpit Patel

Wolfe Research

BuyUpgrades

$23.00

Aug 24

Zacks Equity Research

HoldInitiates Coverage

Aug 22

Matt Phipps

William Blair

BuyMaintains

Aug 13

Stephen Willey

Stifel Nicolaus

BuyMaintains

$35.00

Aug 11

Oliver McCammon

LifeSci Capital

BuyMaintains

$60.00

Aug 7

Boris Peaker

JonesTrading

BuyMaintains

$28.00

Aug 7

Kelsey Goodwin

Piper Sandler

BuyMaintains

$26.00

Aug 7

Supawat Thongthip

Truist

BuyMaintains

Aug 7

Etzer Darout

Barclays

SellMaintains

$14.00

Aug 7

Alec Stranahan

BofA Securities

BuyReiterates

$21.00 → $22.00

Aug 7

Bradley Canino

Guggenheim

BuyInitiates Coverage

$58.00 → $55.00

Aug 6

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 1, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for JANX?

The analyst consensus rating for JANX is Buy, based on the latest ratings from 12 analysts over the last 90 days.

What is the average price target for JANX?

The average 12-month price target for JANX is $34.22, representing an upside of 107.3% from the Oct 16, 2026 close of $16.51.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.